{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:05:01Z","timestamp":1771639501931,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":48,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.phro.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T05:19:47Z","timestamp":1645593587000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence"],"prefix":"10.1016","volume":"21","author":[{"given":"R.","family":"Chuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Glassborow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Speight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Radhakrishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Aspin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Aldred","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2022.02.010_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.phro.2022.02.010_b0010","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(03)00632-1","article-title":"Long-term multi-institutional analysis of stage T1\u2013T2 prostate cancer treated with radiotherapy in the PSA era","volume":"57","author":"Kuban","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2022.02.010_b0015","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phro.2022.02.010_b0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2017.09.030","article-title":"Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review","volume":"125","author":"Murray","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3857\/roj.2016.02005","article-title":"Radiotherapy for locally recurrent rectal cancer treated with surgery alone as the initial treatment","volume":"35","author":"Tanaka","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.phro.2022.02.010_b0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2019.05.021","article-title":"Practical effectiveness of re-irradiation with or without surgery for locoregional recurrence of rectal cancer: A meta-analysis and systematic review","volume":"140","author":"Lee","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0035","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","article-title":"Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer","volume":"125","author":"Schmidt","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/14737140.2020.1822742","article-title":"Prostate re-irradiation: current concerns and future perspectives","volume":"20","author":"Cuccia","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.phro.2022.02.010_b0045","unstructured":"NHS England. Commissioning through evaluation: Standards for the provision of Stereotactic Ablative Radiotherapy. NHS England. 2016."},{"key":"10.1016\/j.phro.2022.02.010_b0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7785\/tcrt.2012.500261","article-title":"Re-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region","volume":"11","author":"Abusaris","year":"2012","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.phro.2022.02.010_b0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/srao.2000.6593","article-title":"Tissue tolerance to reirradiation","volume":"10","author":"Nieder","year":"2000","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14338\/IJPT.13-00002.1","article-title":"Proton reirradiation of recurrent rectal cancer: dosimetric comparison, toxicities, and preliminary outcomes","volume":"1","author":"Berman","year":"2014","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.phro.2022.02.010_b0065","doi-asserted-by":"crossref","first-page":"100595","DOI":"10.1016\/j.adro.2020.10.008","article-title":"Reirradiation for rectal cancer using pencil beam scanning proton therapy: A single institutional experience","volume":"6","author":"Koroulakis","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0070","unstructured":"Stereotactic Ablative Body Radiotherapy (SBRT): A Resource. 2019. Available from: https:\/\/www.sabr.org.uk\/wp-content\/ uploads\/2019\/04\/SABRconsortiumguidelines-2019-v6.1.0.pdf. Accessed 24\/11\/21."},{"key":"10.1016\/j.phro.2022.02.010_b0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.semradonc.2018.02.009","article-title":"Concepts of PTV and robustness in passively scattered and pencil beam scanning proton therapy","volume":"28","author":"Langen","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.clon.2020.03.014","article-title":"Comparing proton to photon radiotherapy plans: UK consensus guidance for reporting under uncertainty for clinical trials","volume":"32","author":"Lowe","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int J Radiat Onco Biol Phys"},{"key":"10.1016\/j.phro.2022.02.010_b0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ijrobp.2013.08.027","article-title":"Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma","volume":"87","author":"Clivio","year":"2013","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1016\/j.phro.2022.02.010_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0402-z","volume":"10","author":"Marnitz","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0105","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijrobp.2016.07.033","article-title":"The price of target dose uniformity","volume":"96","author":"Craft","year":"2016","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1016\/j.phro.2022.02.010_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6649-8-5","article-title":"Influence of increased target dose inhomogeneity on margins for breathing motion compensation in conformal stereotactic body radiotherapy","volume":"8","author":"Richter","year":"2008","journal-title":"BMC Med Phys"},{"key":"10.1016\/j.phro.2022.02.010_b0115","first-page":"59","article-title":"Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies","volume":"19","author":"Moningi","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.phro.2022.02.010_b0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clon.2021.11.002","article-title":"Stereotactic re-irradiation in recurrent prostate cancer after previous postoperative or definitive radiotherapy: long-term results after a median follow-up of 4 years","volume":"34","author":"Francolini","year":"2022","journal-title":"Clin Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631622000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631622000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:15:06Z","timestamp":1762503306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631622000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"alternative-id":["S2405631622000161"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2022.02.010","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}